“The current diagnostic testing regulatory system—in which tests are regulated according to where they are developed and used, rather than the risk they pose if they are inaccurate—creates double standards and potential loopholes that undermine public health objectives.” OR “The Centers for Medicare & Medicaid Services (CMS) regulates labs but has limited insight into the quality, reliability, or usefulness of LDTs, including whether patients have been harmed as a result of their use.”
Recent Posts
- The Center for Genomic Interpretation Launches ELEVATEGENETICS VERIFY
- March 2023 – The Data Driven Point of View
- Center For Genomic Interpretation Seeks Nominations of ELEVATEGENETICS Acceptable Thresholds Committee
- Jan/Feb 2023 – The Data Driven Point of View
- The Business of Labs Negatively Impacts the Potential Outcomes for Patients
Recent Comments